# To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism

> **NCT02265484** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 50 (actual)

## Conditions studied

- Cirrhosis Related Parkinsonism

## Interventions

- **DRUG:** Lactulose+Rifaximin +Bromocriptine

## Key facts

- **NCT ID:** NCT02265484
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02265484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02265484, "To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02265484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*